Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

Why precision medicine?

Precision medicine and PMI

Please note: Once you watch the video, data will be transmitted to Youtube/Google. For more information, see Google Privacy.

Cluster news


Blood group co-determines composition of the intestinal microbiome

In a large genome study, a Kiel University research team demonstrates correlations between certain gene variants and the composition of bacterial colonization in the human body

portrait picture

Robert Huber becomes new OSA Fellow

PMI Steering Committee member Prof. Robert Huber was elected Fellow of the Optical Society of America (OSA).

Microscope image

Undetected and difficult to treat: multidrug resistant tuberculosis strain

Research team finds multidrug resistant TB-strain in Eswatini, that is not detected by modern diagnostic methods and has developed resistance to the new antibiotic bedaquiline.

Mikroskopische Aufnahme von SARS-CoV-2-Viren

COVID-19: contact with cold viruses apparently offers no protection

In contrast, the immune memory could instead contribute to severe disease progressions, as shown by a Kiel research team from the Cluster of Excellence PMI.